Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NeuroPace (NPCE)
NASDAQ:NPCE
NeuroPace (NPCE) Stock Price & Analysis
93 Followers
NPCE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.80 - $18.15
Previous Close$13.4
Volume108.24K
Average Volume (3M)109.08K
Market Cap
$379.82M
Enterprise Value$390.16M
Total Cash (Recent Filing)$61.35M
Total Debt (Recent Filing)$71.69M
Price to Earnings (P/E)-10.5
Beta1.67
Next Earnings
May 09, 2024EPS Estimate
-$0.32Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.28
Shares Outstanding28,344,637
10 Day Avg. Volume202,905
30 Day Avg. Volume109,080
Standard Deviation0.46
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)18.53
Price to Sales (P/S)8.34
Price to Cash Flow (P/CF)-29.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.48
Enterprise Value/Gross Profit12.01
Enterprise Value/Ebitda-13.46
Forecast
1Y Price Target
$17.71Price Target Upside26.14% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
NeuroPace News
PremiumStock Analysis & Ideas
‘Time to Hit Buy,’ Says Wells Fargo About These 2 Stocks
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
NPCE FAQ
What was NeuroPace’s price range in the past 12 months?
NeuroPace lowest stock price was $3.79 and its highest was $18.15 in the past 12 months.
What is NeuroPace’s market cap?
Currently, no data Available
When is NeuroPace’s upcoming earnings report date?
NeuroPace’s upcoming earnings report date is May 09, 2024 which is in 16 days.
How were NeuroPace’s earnings last quarter?
NeuroPace released its earnings results on Mar 05, 2024. The company reported -$0.23 earnings per share for the quarter, beating the consensus estimate of -$0.315 by $0.085.
Is NeuroPace overvalued?
According to Wall Street analysts NeuroPace’s price is currently Undervalued.
Does NeuroPace pay dividends?
NeuroPace does not currently pay dividends.
What is NeuroPace’s EPS estimate?
NeuroPace’s EPS estimate is -$0.32.
How many shares outstanding does NeuroPace have?
NeuroPace has 28,344,637 shares outstanding.
What happened to NeuroPace’s price movement after its last earnings report?
NeuroPace reported an EPS of -$0.23 in its last earnings report, beating expectations of -$0.315. Following the earnings report the stock price went down -1.549%.
Which hedge fund is a major shareholder of NeuroPace?
Currently, no hedge funds are holding shares in NPCE
---
NeuroPace Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$17.71 (26.14% Upside)
$17.71 (26.14% Upside)
Blogger Sentiment
Bullish
NPCE Sentiment 100%
Sector Average 70%
Sector Average 70%
Insider Transactions
Sold Shares
Worth $7.0M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
179.16%
12-Months-Change
Fundamentals
Return on Equity
-118.91%
Trailing 12-Months
Asset Growth
-5.66%
Trailing 12-Months
Company Description
NeuroPace
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
---
NPCE Earnings Call
Q4 2024
0:00 / 0:00
---
NPCE Stock 12 Months Forecast
Average Price Target
$17.71
▲(26.14% Upside)
Technical Analysis
Best Analysts Covering NPCE
1 Year
1 Year Success Rate
11/12 ratings generated profit
1 Year Average Return
+141.43%
reiterated a buy rating 2 months ago
Copying Frank Takkinen's trades and holding each position for 1 Year would result in 91.67% of your transactions generating a profit, with an average return of +141.43% per trade.
---